Vasoactive Thiomethyl-Pyrimidines: Promising Drug Candidates with Vascular Activity
Main Author: | |
---|---|
Publication Date: | 2017 |
Other Authors: | , , , , |
Format: | Article |
Language: | eng |
Source: | Journal of the Brazilian Chemical Society (Online) |
Download full: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0103-50532017000701266 |
Summary: | Pyrimidines and their derivatives are present in various biologically active molecules. Most of the synthetic methods employed to achieve the pyrimidinone ring consist of two stages: the synthesis of a Michael intermediate from an aldehyde and an "active methylene" containing compound; and the condensation of this intermediate with a molecule containing an uranium moiety. This may take one to two days of laboratory work. In this paper we describe a new methodology in which these derivatives are obtained via multicomponent synthesis mediated by ultrasound in only 2 hours. In order to obtain water-soluble pyrimidinone derivatives, our previous compounds were further converted into their sodium salts. In pharmacologic studies, these salts inhibited phenylephrine-induced contraction in isolated rat aorta, suggesting that they may act as alpha-1 antagonists and, therefore, are candidates for anti-hypertensive drugs. |
id |
SBQ-2_263bf52e986d672dd605050e84f10f51 |
---|---|
oai_identifier_str |
oai:scielo:S0103-50532017000701266 |
network_acronym_str |
SBQ-2 |
network_name_str |
Journal of the Brazilian Chemical Society (Online) |
repository_id_str |
|
spelling |
Vasoactive Thiomethyl-Pyrimidines: Promising Drug Candidates with Vascular Activitypyrimidinesvascular activityhypertensiondrug discoveryultrasoundPyrimidines and their derivatives are present in various biologically active molecules. Most of the synthetic methods employed to achieve the pyrimidinone ring consist of two stages: the synthesis of a Michael intermediate from an aldehyde and an "active methylene" containing compound; and the condensation of this intermediate with a molecule containing an uranium moiety. This may take one to two days of laboratory work. In this paper we describe a new methodology in which these derivatives are obtained via multicomponent synthesis mediated by ultrasound in only 2 hours. In order to obtain water-soluble pyrimidinone derivatives, our previous compounds were further converted into their sodium salts. In pharmacologic studies, these salts inhibited phenylephrine-induced contraction in isolated rat aorta, suggesting that they may act as alpha-1 antagonists and, therefore, are candidates for anti-hypertensive drugs.Sociedade Brasileira de Química2017-07-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0103-50532017000701266Journal of the Brazilian Chemical Society v.28 n.7 2017reponame:Journal of the Brazilian Chemical Society (Online)instname:Sociedade Brasileira de Química (SBQ)instacron:SBQ10.21577/0103-5053.20160289info:eu-repo/semantics/openAccessAndrade,Audrey N. deAraújo,Alice V.Barbosa,Hugo B. W.Wanderley,Almir G.Malta,Oscar L.Anjos,Janaína V. doseng2017-06-23T00:00:00Zoai:scielo:S0103-50532017000701266Revistahttp://jbcs.sbq.org.brONGhttps://old.scielo.br/oai/scielo-oai.php||office@jbcs.sbq.org.br1678-47900103-5053opendoar:2017-06-23T00:00Journal of the Brazilian Chemical Society (Online) - Sociedade Brasileira de Química (SBQ)false |
dc.title.none.fl_str_mv |
Vasoactive Thiomethyl-Pyrimidines: Promising Drug Candidates with Vascular Activity |
title |
Vasoactive Thiomethyl-Pyrimidines: Promising Drug Candidates with Vascular Activity |
spellingShingle |
Vasoactive Thiomethyl-Pyrimidines: Promising Drug Candidates with Vascular Activity Andrade,Audrey N. de pyrimidines vascular activity hypertension drug discovery ultrasound |
title_short |
Vasoactive Thiomethyl-Pyrimidines: Promising Drug Candidates with Vascular Activity |
title_full |
Vasoactive Thiomethyl-Pyrimidines: Promising Drug Candidates with Vascular Activity |
title_fullStr |
Vasoactive Thiomethyl-Pyrimidines: Promising Drug Candidates with Vascular Activity |
title_full_unstemmed |
Vasoactive Thiomethyl-Pyrimidines: Promising Drug Candidates with Vascular Activity |
title_sort |
Vasoactive Thiomethyl-Pyrimidines: Promising Drug Candidates with Vascular Activity |
author |
Andrade,Audrey N. de |
author_facet |
Andrade,Audrey N. de Araújo,Alice V. Barbosa,Hugo B. W. Wanderley,Almir G. Malta,Oscar L. Anjos,Janaína V. dos |
author_role |
author |
author2 |
Araújo,Alice V. Barbosa,Hugo B. W. Wanderley,Almir G. Malta,Oscar L. Anjos,Janaína V. dos |
author2_role |
author author author author author |
dc.contributor.author.fl_str_mv |
Andrade,Audrey N. de Araújo,Alice V. Barbosa,Hugo B. W. Wanderley,Almir G. Malta,Oscar L. Anjos,Janaína V. dos |
dc.subject.por.fl_str_mv |
pyrimidines vascular activity hypertension drug discovery ultrasound |
topic |
pyrimidines vascular activity hypertension drug discovery ultrasound |
description |
Pyrimidines and their derivatives are present in various biologically active molecules. Most of the synthetic methods employed to achieve the pyrimidinone ring consist of two stages: the synthesis of a Michael intermediate from an aldehyde and an "active methylene" containing compound; and the condensation of this intermediate with a molecule containing an uranium moiety. This may take one to two days of laboratory work. In this paper we describe a new methodology in which these derivatives are obtained via multicomponent synthesis mediated by ultrasound in only 2 hours. In order to obtain water-soluble pyrimidinone derivatives, our previous compounds were further converted into their sodium salts. In pharmacologic studies, these salts inhibited phenylephrine-induced contraction in isolated rat aorta, suggesting that they may act as alpha-1 antagonists and, therefore, are candidates for anti-hypertensive drugs. |
publishDate |
2017 |
dc.date.none.fl_str_mv |
2017-07-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0103-50532017000701266 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0103-50532017000701266 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.21577/0103-5053.20160289 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Sociedade Brasileira de Química |
publisher.none.fl_str_mv |
Sociedade Brasileira de Química |
dc.source.none.fl_str_mv |
Journal of the Brazilian Chemical Society v.28 n.7 2017 reponame:Journal of the Brazilian Chemical Society (Online) instname:Sociedade Brasileira de Química (SBQ) instacron:SBQ |
instname_str |
Sociedade Brasileira de Química (SBQ) |
instacron_str |
SBQ |
institution |
SBQ |
reponame_str |
Journal of the Brazilian Chemical Society (Online) |
collection |
Journal of the Brazilian Chemical Society (Online) |
repository.name.fl_str_mv |
Journal of the Brazilian Chemical Society (Online) - Sociedade Brasileira de Química (SBQ) |
repository.mail.fl_str_mv |
||office@jbcs.sbq.org.br |
_version_ |
1750318179606855680 |